Received Jan 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | EN939 | — |
Bexsero was inside a box of Bexsero vaccines with an expiration date of 2026 that was labeled on the outside of the Box.; Product Complaint; Expired dose of Bexsero administered to a patient./ reported an expired dose (31Oct2024) of Bexsero was administered to a patient on 14Jan2026.; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 19-year-old male patient who received Men B NVS (Bexsero) (batch number EN939, expiry date 31-OCT-2024) for prophylaxis. This case was associated with a product complaint. On 14-JAN-2026, the patient received Bexsero. On 14-JAN-2026, an unknown time after receiving Bexsero, the patient experienced expired vaccine used (Verbatim: Expired dose of Bexsero administered to a patient./ reported an expired dose (31Oct2024) of Bexsero was administered to a patient on 14Jan2026.). On an unknown date, the patient experienced carton label issue (Verbatim: Bexsero was inside a box of Bexsero vaccines with an expiration date of 2026 that was labeled on the outside of the Box.) and pharmaceutical product complaint (Verbatim: Product Complaint). The outcome of the expired vaccine used, carton label issue and pharmaceutical product complaint were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-JAN-2026 The expired syringe (dose) of Bexsero, dated 31-Oct-2024, had been placed inside a box of Bexsero vaccines that displayed an expiration date of 2026 on the outside of the box.